Germ Warfare Grants: NIH's Closed Door Disease Review
Published Date: 12/16/2025
Notice
Summary
The NIH’s Center for Scientific Review is holding a closed virtual meeting on January 13-14, 2026, to review important grant applications about infectious diseases. These meetings are private to protect secret research info and personal details. Scientists applying for grants should note this review could impact funding decisions soon.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Closed Grant Review Meeting Scheduled
If you are a scientist who applied for NIH grants about infectious diseases, your applications will be reviewed in a closed virtual meeting on January 13-14, 2026. This review could affect upcoming funding decisions for those grant applications.
Applicant Confidentiality Protections
The meetings will be closed to protect confidential trade secrets, patentable material, and personal information. NIH says the closure follows Title 5 U.S.C. sections 552b(c)(4) and 552b(c)(6) to prevent unwarranted invasions of privacy.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06501 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a cool new invention—special human antibodies that can fight certain cancers and autoimmune diseases—for companies to license and develop into treatments. This means businesses can jump on this opportunity to create powerful new medicines using government-backed research. Interested parties should act soon and may need to sign agreements to get full details.
2026-06283 — Prospective Grant of an Exclusive Patent License: Pigment Epithelium-Derived Factor (PEDF) Peptides and Use for Treating Retinal Degeneration
The National Eye Institute plans to give Perpetual Biosciences, Inc. an exclusive license to use special PEDF peptides to treat eye diseases that cause vision loss. This means the company will have the sole right to develop and sell this promising treatment, potentially helping millions with retinal degeneration. If you want to comment or apply for a license, act fast—submissions close April 16, 2026!
2026-05957 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in April 2026 to review and decide on important research grant applications. These meetings affect scientists seeking funding in areas like neuroscience, cancer, and liver disease. No public access is allowed to protect private info and trade secrets, and these reviews help decide where millions in research money will go.
2026-05672 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
The National Institute on Deafness and Other Communication Disorders is holding two closed meetings in late April and early May 2026 to review grant applications and evaluate researchers’ qualifications. These meetings affect scientists seeking funding and help ensure top-notch research gets supported. No public access means privacy is protected, and the process keeps the money flowing to the best projects on time.
2026-05673 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on April 17, 2026, to review and evaluate important grant applications in health and science fields. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-05738 — Submission for OMB Review; 30-Day Comment Request; National Institutes of Health (NIH) Loan Repayment Programs, (Office of the Director)
The NIH is asking for a 30-day public comment on extending its Loan Repayment Programs that help doctors and scientists pay off their student loans while they do important health research. This extension keeps the program running smoothly with no big changes, and comments are due by April 23, 2026. If you’re a researcher with student loans, this program could save you money while you help improve health!
Previous / Next Documents
Previous: 2025-22991 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding a closed virtual meeting on January 5, 2026, to review important grant applications in neurology and neuropsychiatry. These meetings are private to protect secret research ideas and personal info. Scientists applying for grants and NIH staff are the main players, with no new costs or timing changes announced.
Next: 2025-22993 — National Center for Complementary & Integrative Health; Notice of Meeting
The National Center for Complementary & Integrative Health is holding a virtual meeting on April 17, 2026, to review grant applications and share updates on their latest projects. This meeting affects researchers and the public interested in complementary health studies, with a chance to submit comments by April 3. It’s a key moment for funding decisions and learning about new health research, all happening online for easy access.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in